Lin SR

ORCID: 0000-0002-4160-2361 · 1 paper in corpus

2019

The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo.

Therapeutic advances in chronic disease ·doi:10.1177/2040622319875305

Dipeptidyl peptidase IV (DPP-4), an incretin glucagon-like peptide-1 (GLP-1) degrading enzyme, contains two forms and it can exert various physiological functions particular in controlling blood glucose through the action of GLP-1. In diabe…